SMARCC1 and cancer: Following induction of DNA damage by Dox, SMARCC1 immunoprecipitation of the chromatin-bound fraction in cancer cells without ASS1 demonstrated decreased levels of SMARCC1 protein and lower levels of succinated SMARCC1 (Fig. 4b).